Main Article Content

Abstract

ABSTRACT
Background. Surgical or transcatheter techniques have been the mainstay therapy for atrial septal defects (ASDs) over the past decades. Few data with regard to ASDs management have been published to date in Sub-Saharan Africa. This paper reviews the early and intermediate results following surgical repair of ASDs in a Central African institution. Patients and methods. Between December 2009 and November 2022, a total of 46 patients underwent surgical closure for ASDs in our unit. Their files were retrospectively reviewed, and clinical data were analysed. Results. The mean age was 23.9 ± 17.8 years (range: 1.4–55 years). Female sex was predominant with a sex-ratio (M/F) of 0.76. Patients aged > 18 years were the majority (n = 27/46, 58.6%). The main symptoms were dyspnea (16/46, 34.7%) and palpitations (20/46, 43.4%) or both (10/46, 21.7%). Ostium secundum (OS) was the commonest type of ASD (93.5%, 43/46). The mean ASD size was 3.2 ± 1.8 mm. Moderate pulmonary hypertension was found in 6.5% (3/46) of the patients. Associated procedures were Patent Ductus Arteriosus (PDA) ligation (2/46, 4.3%) and tricuspid valve annuloplasty (6/46, 13.0%). Operative mortality was 2.1% (1/46). Postoperative complications were cardiac arrythmias (10.8%, 5/46) and bleeding requiring chest re-exploration (2.1%, 1/46). The mean intensive care unit length of stay was 3.2 ± 1.2 days. The six-year overall survival was 89.4 ± 7.3%. Conclusion. The early and intermediate outcomes of surgical closure of ASDs in our context seem to be associated with low rates of mortality and morbidity.
RÉSUMÉ
Introduction. Au cours des dernières décennies, les techniques chirurgicales ou de transcathéter ont constitué le traitement de base des communications interauriculaires (CIA). Peu de données concernant la prise en charge des CIA ont été publiées à ce jour en Afrique subsaharienne. Cet article passe en revue les résultats précoces et intermédiaires de la réparation chirurgicale des CIA dans une institution d'Afrique centrale. Patients et méthodes. Entre décembre 2009 et novembre 2022, 46 patients au total ont subi une fermeture chirurgicale pour des CIA dans notre unité. Leurs dossiers ont été revus rétrospectivement et les données cliniques ont été analysées. Résultats. L'âge moyen était de 23,9 ± 17,8 ans (intervalle : 1,4-55 ans). Le sexe féminin était prédominant avec un sex-ratio (M/F) de 0,76. Les patients âgés de plus de 18 ans étaient majoritaires (n = 27/46, 58,6 %). Les principaux symptômes étaient la dyspnée (16/46, 34,7 %) et les palpitations (20/46, 43,4 %) ou les deux (10/46, 21,7 %). L'ostium secundum (OS) était le type de CIA le plus fréquent (93,5 %, 43/46). La taille moyenne de la CIA était de 3,2 ± 1,8 mm. Une hypertension pulmonaire modérée a été constatée chez 6,5 % (3/46) des patients. Les interventions associées étaient la ligature du canal artériel (2/46, 4,3 %) et l'annuloplastie de la valve tricuspide (6/46, 13,0 %). La mortalité opératoire était de 2,1 % (1/46). Les complications postopératoires ont été des arythmies cardiaques (10,8 %, 5/46) et des hémorragies nécessitant une ré exploration thoracique (2,1 %, 1/46). La durée moyenne du séjour en unité de soins intensifs était de 3,2 ± 1,2 jours. La survie globale à six ans était de 89,4 ± 7,3 %. Conclusion. Dans notre contexte, les résultats précoces et intermédiaires de la fermeture chirurgicale des CIA semblent être associés à de faibles taux de mortalité et de morbidité.

Keywords

atrial septal defects; cardiac surgery; Central Africa communication interauriculaire; chirurgie cardiaque; Afrique centrale

Article Details

How to Cite
Mve MVONDO, C., Kobe Zephanie Fokalbo, NGO Yon, L. C., Tsague Kengni , H. N., Banga Nkomo , D., Metogo Mbengono, J. A., Lowe Kuissu , S., Ela Bella , A., Yepmo Nana, Y., Ngatchou Djomo , W., & Ngowe Ngowe , M. (2024). Atrial Septal Defects Repair in Central Africa: Early and Intermediate-term Results. HEALTH SCIENCES AND DISEASE, 25(4). https://doi.org/10.5281/hsd.v25i4.5541

References

  1. Geva T, Martins JD, Wald RM. Atrial septal defects. Lancet 383: 1921-1932, 2014
  2. van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide. A systematic review and meta-analysis. J Am Coll Cardiol 2011;58:2241-7
  3. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, So-ciety for Cardiovascular Angiography and Interventions, and Society of Thoracic Sur-geons. J Am Coll Cardiol. 2008;52:e143–263
  4. Le Gloan L, Legendre A, Iserin L, Ladouceur M. Pathophysiology and natural history of atrial septal defect. J Thorac Dis. 2018 Sep;10 (Suppl 24):S2854-S2863. doi: 10.21037/jtd.2018.02.80. PMID: 30305945; PMCID: PMC6174151.
  5. Kuijpers JM, Mulder BJ, Bouma BJ. Secundum atrial septal defect in adults: a practi-cal review and recent developments. Neth Heart J. 2015 Apr;23(4):205-11. doi: 10.1007/s12471-015-0663-z. PMID: 25884091; PMCID: PMC4368528.
  6. Akagi T. Current concept of transcatheter closure of atrial septal defect in adults. J Cardiol. 2015 Jan;65(1):17-25. doi: 10.1016/j.jjcc.2014.09.002. Epub 2014 Oct 11. PMID: 25308548.
  7. Tanaka S, Imamura T, Narang N, Fukuda N, Ueno H, Kinugawa K. Practical Thera-peutic Management of Percutaneous Atrial Septal Defect Closure. Intern Med. 2022 Jan 1;61(1):15-22. doi: 10.2169/internalmedicine.5944-20. Epub 2021 Feb 15. PMID: 33583888; PMCID: PMC8810241.
  8. Butera G, Biondi-Zoccai G, Sangiorgi G, Abella R, Giamberti A, Bussadori C, Sheiban I, Saliba Z, Santoro T, Pelissero G, Carminati M, Frigiola A. Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and me-ta-analysis of currently available clinical evidence. EuroIntervention. 2011 Jul;7(3):377-85. doi: 10.4244/EIJV7I3A63. PMID: 21729841.
  9. Jalal Z, Hascoët S, Gronier C, Godart F, Mauri L, Dauphin C, Lefort B, Lachaud M, Piot D, Dinet ML, Levy Y, Fraisse A, Ovaert C, Pillois X, Lusson JR, Petit J, Ba-ruteau AE, Thambo JB. Long-Term Outcomes After Percutaneous Closure of Ostium Secundum Atrial Septal Defect in the Young: A Nationwide Cohort Study. JACC Cardiovasc Interv. 2018 Apr 23;11(8):795-804. doi: 10.1016/j.jcin.2018.01.262. PMID: 29673513.
  10. Hansen JH, Duong P, Jivanji SGM, Jones M, Kabir S, Butera G, Qureshi SA, Rosenthal E. Transcatheter Correction of Superior Sinus Venosus Atrial Septal Defects as an Alternative to Surgical Treatment. J Am Coll Cardiol. 2020 Mar 24;75(11):1266-1278. doi: 10.1016/j.jacc.2019.12.070. PMID: 32192652.
  11. Kinda G, Millogo GR, Koueta F, Dao L, Talbousouma S, Cissé H, Djiguimdé A, Yé D, Sorgho CL. Cardiopathies congénitales: aspects épidémiologiques et échocardiographies à propos de 109 cas au centre hospitalier universitaire pédiatrique Charles de Gaulle (CHUP-CDG) de Ouagadougou, Burkina Faso [Congenital heart disease: epidemiological and echocardiography aspects about 109 cases in Pediatric Teaching Hospital Charles de Gaulle (CDG CHUP) in Ouagadougou, Burkina Faso]. Pan Afr Med J. 2015 Jan 29;20:81. French. doi: 10.11604/pamj.2015.20.81.5624. PMID: 26090039; PMCID: PMC4450055.
  12. Yangni-Angate KH, Meneas C, Diby F, Diomande M, Adoubi A, Tanauh Y. Cardiac surgery in Africa: a thirty-five year experience on open heart surgery in Cote d'Ivoire. Cardiovasc Diagn Ther. 2016 Oct;6(Suppl 1):S44-S63. doi: 10.21037/cdt.2016.10.06. PMID: 27904843; PMCID: PMC5119994.
  13. Agwar FD, Tekleab AM. Heart surgery by the locals in resource-limited settings: The experience from Ethiopia. JTCVS Open. 2022 Feb 3;9:98-105. doi: 10.1016/j.xjon.2022.01.004. PMID: 36003472; PMCID: PMC9390689.
  14. Ambassa JC, Charles M, Jacques Cabral TT. Heart catheterization in adults in a sub-Saharan tertiary centre: 8 years' experience. Cardiovasc Diagn Ther. 2019 Apr;9(2):173-178. doi: 10.21037/cdt.2018.11.07. PMID: 31143639; PMCID: PMC6511676..
  15. Chambault AL, Olsen K, Brown LJ, Mellor SL, Sorathia N, Thomas AE, Kothari N, Harky A. Transcatheter versus surgical closure of atrial septal defects: a systematic review and meta-analysis of clinical outcomes. Cardiol Young. 2022 Jan;32(1):1-9. doi: 10.1017/S1047951121004583. Epub 2021 Nov 25. PMID: 34819196.
  16. Rigatelli G, Zuin M, Roncon L, Nanjiundappa A. Secundum atrial septal defects transcatheter closure versus surgery in adulthood: a 2000-2020 systematic review and meta-analysis of intrahospital outcomes. Cardiol Young. 2021 Apr;31(4):541-546. doi: 10.1017/S1047951121001232. Epub 2021 Apr 8. PMID: 33827735.
  17. Lindsey JB, Hillis LD. Clinical update: atrial septal defect in adults. Lancet. 2007 Apr 14;369(9569):1244-1246. doi: 10.1016/S0140-6736(07)60576-5. PMID: 17434386.
  18. Zhou Q, Lai Y, Wei H, Song R, Wu Y, Zhang H. Uidirectional valve patch for repair of cardiac septal defects with pulmonary hypertension. Ann Thorac Surg. 1995;60:1245-9. 5.
  19. Zhang B, Wu S, Liang J, Zhang G, Jiang G, Zhou M, et al. Unidirectional monovalve homologous aortic patch for repair of ventricular septal defect with pulmonary hypertension. Ann Thorac Surg. 2007;83: 2176-81
  20. Novick WM,Sandoval N, Lazorhysynets VV, Castillo V, Baskevitch A, MoX,etal. Flap valve double patch closure of ventricular septal defects in children with increased pulmonary vascular resistance. Ann Thorac Surg. 2005;79:21-8. 4.
  21. Hui-Li Gan, Jian-Qun Zhang, Zhao-Guang Zhang, Yi Luo, Qi-Wen Zhou, Ping Bo. The unidirectional valve patch provides no benefits to early and long-term survival in patients with ventricular septal defect and severe pulmonary artery hypertension. Volume 139, Issue 4, April 2010, Pages 950-955.
  22. Wang JK, Chiu SN, Lin MT, Chen CA, Lu CW, Wu MH. Transcatheter Closure of Atrial Septal Defect Associated With Pulmonary Artery Hypertension using Fenestrated Devices. Am J Cardiol. 2021 May 15;147:122-128. doi: 10.1016/j.amjcard.2021.01.025. Epub 2021 Mar 3. PMID: 33667439.
  23. Wu HC, Wang CC, Fu YC, Jan SL, Wei HJ, Lin YK, Chang Y. Surgical Management for Complications during Closure of Atrial Septal Defect with Amplatzer Device. Acta Cardiol Sin. 2013 Nov;29(6):557-61. PMID: 27122757; PMCID: PMC4805035.
  24. Raghuram AR, Krishnan R, Kumar S, Balamurugan K. Complications in atrial septal defect device closure. Interact Cardiovasc Thorac Surg. 2008 Feb;7(1):167-9. doi: 10.1510/icvts.2007.165647. Epub 2007 Nov 5. PMID: 17984170.

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.